NCT05637151

Brief Summary

Objective:The aim of this study was to investigate the relationship between delayed cord clamping and neonatal bilirubin levels in pregnant women with intrahepatic cholestasis of pregnancy. Method:This observational prospective cohort study included a total of 200 pregnant women at 37-40 gestational weeks. Among them, 100 pregnant women with intrahepatic cholestasis of pregnancy were divided into 50 cases of immediate cord clamping group (ICC in pregnant women with ICP)and 50 cases of delayed cord clamping group(DCC in pregnant women with ICP), and 100 normal pregnant women were also divided into 50 cases of immediate cord clamping group (ICC in normal pregnant women)and 50 cases of delayed cord clamping group(DCC in normal pregnant women). The bilirubin levels of neonates in each group were compared.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 28, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 5, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

February 22, 2023

Status Verified

February 1, 2023

Enrollment Period

1 year

First QC Date

November 28, 2022

Last Update Submit

February 19, 2023

Conditions

Keywords

Intrahepatic cholestasis during pregnancyneonatal bilirubinbilirubinICPneonatal jaundice

Outcome Measures

Primary Outcomes (1)

  • the neonatal bilirubin values

    the neonatal bilirubin values

    2-4 days after birth

Study Arms (4)

ICC in pregnant women with ICP

OTHER

Immediate cord clamping group in pregnant women with intrahepatic cholestasis of pregnancy

Other: clamp time of umbilical

DCC in pregnant women with ICP

EXPERIMENTAL

Delayed cord clamping group in pregnant women with intrahepatic cholestasis of pregnancy

Other: clamp time of umbilical

ICC in normal pregnant women

OTHER

Immediate cord clamping group in normal pregnant women

Other: clamp time of umbilical

DCC in normal pregnant women

EXPERIMENTAL

Delayed cord clamping group in normal pregnant women

Other: clamp time of umbilical

Interventions

The umbilical cord was clamped immediately or late for more than 30s

DCC in normal pregnant womenDCC in pregnant women with ICPICC in normal pregnant womenICC in pregnant women with ICP

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • The pregnant woman is born at a gestational age of 37-40 weeks;
  • The pregnant woman has a single child;
  • Regular obstetric examination durinv pregnancy with complete obstetric examination data was diagnosed as intrahepatic cholestasis of pregnancy(ICP).

You may not qualify if:

  • Pregnancy complicated with medical and surgical diseases, such as thyroiddysfunction and chronic hypertension;
  • Insufficiency of vital organ function or complicated tumor;
  • Pregnant women with other pregnancy complications besides ICP, such as preeclampsia, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, 325027, China

RECRUITING

MeSH Terms

Conditions

Intrahepatic Cholestasis of PregnancyJaundice, Neonatal

Condition Hierarchy (Ancestors)

Hyperbilirubinemia, NeonatalInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHyperbilirubinemiaPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ying Hua

    Second Affiliated Hospital of Wenzhou Medical University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2022

First Posted

December 5, 2022

Study Start

December 1, 2022

Primary Completion

December 1, 2023

Study Completion

June 1, 2024

Last Updated

February 22, 2023

Record last verified: 2023-02

Locations